India  

Novavax: Fourth Covid Vaccine Could Be Approved in the UK

Video Credit: ODN - Duration: 01:22s - Published
Novavax: Fourth Covid Vaccine Could Be Approved in the UK

Novavax: Fourth Covid Vaccine Could Be Approved in the UK

A fourth coronavirus vaccine could be approved for use in the UK within weeks as late-stage trials suggested it was 89% effective in preventing Covid-19.

The UK has secured 60 million doses of the Novavax jab, which is believed to offer protection against the new UK and South African variants.

Two vaccines have already been rolled out in the UK – from Pfizer and Oxford/AstraZeneca – while a third from Moderna has been approved for use.

The Novavax jab will be delivered in the second half of 2021 if it receives MHRA approval.

Report by Avagninag.

Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn


You Might Like


💡 newsR Knowledge: Other News Mentions

South Africa South Africa Country in Southern Africa

International Criminal Court considering issuing arrest warrant for Netanyahu [Video]

International Criminal Court considering issuing arrest warrant for Netanyahu

The International Criminal Court is probing Israel's actions in the West Bank and Gaza, independent of other cases at the International Court of Justice, such as South Africa's genocide claims against Israel in Gaza.

Credit: euronews (in English)    Duration: 02:07Published
South Africa celebrates 'Freedom Day': country remembers an historic election every April 27 [Video]

South Africa celebrates 'Freedom Day': country remembers an historic election every April 27

Credit: FRANCE 24 English    Duration: 02:45Published
Study Warns Deadly Ocean Upswells Increasing Due to Climate Crisis [Video]

Study Warns Deadly Ocean Upswells Increasing Due to Climate Crisis

Study Warns Deadly , Ocean Upswells Increasing , Due to Climate Crisis. 'The Guardian' reports that a new study highlights how the climate-disrupted ocean has pushed a number of aquatic species to flee increasing temperatures in the tropics. The forced migration has increasingly resulted in sharks, rays and other species dying amid intense upswells of cold water from the depths of the ocean. In 2021, extreme cold upswelling off of South Africa's coast caused a mass die-off of over 260 marine organisms from 81 different species. A recent study found that these upswellings are increasing in both frequency and intensity. . Scientists were able to study the 2021 mass die-off in precise detail, due to one of the victims being a satellite-tagged bull shark. The bull shark died in waters 10 degrees Celsius below the temperature tropical species are accustomed to. Despite the shark's attempts to avoid the cold swell, it could not escape the impacted area before succumbing to hypothermia. 'The Guardian' reports that the team found that the frequency of these cold upswelling events has been increasing since 1981. Other species killed in similar events include whale sharks, bigeye trevallies, convict surgeonfish and the common blacktip shark. . Other species killed in similar events include whale sharks, bigeye trevallies, convict surgeonfish and the common blacktip shark. . Other species killed in similar events include whale sharks, bigeye trevallies, convict surgeonfish and the common blacktip shark. . Other species killed in similar events include whale sharks, bigeye trevallies, convict surgeonfish and the common blacktip shark. . The team's findings were published on April 15 in 'Nature Climate Change.'

Credit: Wibbitz Top Stories    Duration: 01:31Published
South Africa's ex-parliament speaker arrested in graft probe [Video]

South Africa's ex-parliament speaker arrested in graft probe

Credit: FRANCE 24 English    Duration: 02:31Published
South Africa bus crash kills 45 Easter pilgrims from Botswana [Video]

South Africa bus crash kills 45 Easter pilgrims from Botswana

Credit: FRANCE 24 English    Duration: 01:14Published

Pfizer Pfizer American multinational pharmaceutical and biotechnology corporation

Pfizer wins trademark battle in Delhi high court

Delhi high court has permanently restrained use of the ‘Vigoura’ mark by a homeopathic drug maker to sell its medicine for sexual disorders. The decision was..
IndiaTimes

AstraZeneca AstraZeneca British pharmaceutical company

AstraZeneca admits Covishield vaccines raises rare side-effects risk. How worried should you be?

In India, almost 90% of people who received Covid vaccine, received the AstraZeneca vaccine which in India is called Covishield.
DNA

'A shadow of what I was': Dad who suffered brain injury days after getting COVID jab sues AstraZeneca

A dad who suffered a brain injury just days after receiving a British-developed COVID vaccine has told Sky News he would never have had the jab if he had known..
Sky News

Facebook Facebook Social-networking service owned by Meta Platforms

PM helps out in the kitchen with food charity [Video]

PM helps out in the kitchen with food charity

Prime Minister Rishi Sunak has helped to cook meals and prepare food packages with charity volunteers at a community centre in north London. Report by Alibhaiz. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 01:05Published
PM: General election isn't foregone conclusion [Video]

PM: General election isn't foregone conclusion

Prime Minister Rishi Sunak has insisted the general election 'isn’t a foregone conclusion' as he vowed to 'fight incredibly hard' for the country. Report by Alibhaiz. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:51Published
Dodds: Labour has no plans for coalitions with any parties [Video]

Dodds: Labour has no plans for coalitions with any parties

Labour Chair Anneliese Dodds has said Labour is not planning for a coalition with any parties and wants to ensure a majority government. Report by Alibhaiz. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 01:10Published
Harper insists Tories still in with chance at next election [Video]

Harper insists Tories still in with chance at next election

Mark Harper insisted the Conservatives were still in with a chance of winning the next general election, despite the party’s local elections trouncing. Report by Covellm. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:37Published
Tributes paid at vigil for boy killed in Hainault attack [Video]

Tributes paid at vigil for boy killed in Hainault attack

More than 300 people gathered at a vigil on Sunday to pay tribute to Daniel Anjorin, a teenage boy killed in a sword attack while walking to school. A mourning community gathered at the Hainault Underground station car park, just metres away from where the incident happened, on Sunday morning to pay tribute to Daniel and offer messages of support to his grieving family. Report by Covellm. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:38Published

Related videos from verified sources

Covid update: SII seeks Novavax trial approval; virus may affect sperm quality [Video]

Covid update: SII seeks Novavax trial approval; virus may affect sperm quality

From Delhi schools opening for Classes 9 and 11 to SII seeking trial approval for the Novavax vaccine, here are the top updates on the pandemic. Delhi government on Friday announced the schools for..

Credit: HT Digital Content     Duration: 03:20Published
New Covid vaccine Novavax to be assessed after successful trials [Video]

New Covid vaccine Novavax to be assessed after successful trials

A new Covid-19 vaccine is to be assessed for use in the U.K. after it was shown to be nearly 90 per cent effective.

Credit: Cover Video STUDIO     Duration: 01:01Published
Novavax COVID-19 vaccine appears 89% effective in UK study [Video]

Novavax COVID-19 vaccine appears 89% effective in UK study

While the Novavax vaccine study is still ongoing, initial results show it is nearly 96% effective against the older coronavirus and nearly 86% effective against the new variant circulating in the UK.

Credit: Euronews English     Duration: 02:06Published